Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Rule 2.9 Announcement

14 Dec 2018 07:00



Rule 2.9 Announcement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

14 December 2018

Shire plc

(“Shire” or the “Company”)

Rule 2.9 Announcement

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 13 December 2018, being the last business day prior to the date of this announcement, it had 924,178,050 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting rights in Shire is 916,820,767. The International Securities Identification Number (“ISIN”) for Shire’s ordinary shares is JE00B2QKY057.

Shire has an American Depositary Share (“ADS”) programme for which Citibank, N.A. acts as depositary. One ADS represents three ordinary shares of 5 pence each, with ISIN US82481R1068. The ADSs trade on the NASDAQ Global Select Market.

Enquiries:

Shire plc

Christoph Brackmann (Investor Relations) +41 41 288 4129Sun Kim (Investor Relations) +1 617 588 8175Katie Joyce (Media) +1 781 482 2779


Date   Source Headline
6th Dec 201811:55 amRNSForm 8.3 - Shire plc
6th Dec 201811:38 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
6th Dec 201811:34 amRNSForm 8.3 - Shire plc
6th Dec 201811:34 amBUSFORM 8.3 - SHIRE PLC
6th Dec 201810:56 amRNSForm 8.5 (EPT/RI)
6th Dec 201810:54 amRNSForm 8.5 (EPT/RI)- Shire plc
6th Dec 201810:51 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
6th Dec 201810:49 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
6th Dec 201810:48 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
6th Dec 201810:45 amRNSForm 8.5 (EPT/RI)
6th Dec 201810:36 amRNSForm 8.5 (EPT/NON-RI) - SHIRE PLC
6th Dec 201810:28 amRNSForm 8.5 (EPT/RI)
6th Dec 201810:25 amRNSForm 8.3 - Shire Plc
6th Dec 20188:33 amBUSForm 8.3 - SHIRE PLC AMENDMENT
6th Dec 20188:12 amBUSFORM 8.3 - SHIRE PLC - AMENDMENT
6th Dec 20187:53 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
6th Dec 20187:50 amRNSForm 8.3 - Shire Plc
6th Dec 20187:00 amRNSForm 8.3 - Shire PLC
6th Dec 20187:00 amGNWRule 2.9 Announcement
6th Dec 20187:00 amBUSForm 8.3 - SHIRE PLC
5th Dec 20184:15 pmRNSForm 8.5 (EPT/NON-RI)
5th Dec 20183:41 pmRNSForm 8.5 (EPT/NON-RI)
5th Dec 20183:41 pmRNSForm 8.5 (EPT/NON-RI)
5th Dec 20183:20 pmRNSForm 8.3 - Shire plc
5th Dec 20183:20 pmGNWDavidson Kempner Capital Management LP : Form 8.3 - Shire Plc
5th Dec 20183:20 pmBUSForm 8.3 - Shire PLC
5th Dec 20183:17 pmRNSForm 8.3 - Shire Plc
5th Dec 20183:05 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
5th Dec 20183:04 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
5th Dec 20183:02 pmRNSForm 8.3 - Shire plc
5th Dec 20183:00 pmRNSForm 8.3 - Shire PLC
5th Dec 20183:00 pmBUSForm 8.3 - Shire PLC
5th Dec 20182:53 pmRNSForm 8.3 - Shire plc
5th Dec 20182:42 pmRNSForm 8.3 - Shire Plc
5th Dec 20182:28 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire plc
5th Dec 20181:57 pmEQSForm 8.3 - The Vanguard Group, Inc.: Shire plc
5th Dec 20181:51 pmRNSForm 8.3 - [Shire Plc]
5th Dec 20181:35 pmGNWResults of Court Meeting and Shire General Meeting
5th Dec 20181:09 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
5th Dec 20181:07 pmRNSForm 8.3 - Shire plc
5th Dec 201812:45 pmRNSForm 8.3 - Takeda Pharmaceutical
5th Dec 201812:43 pmRNSForm 8.3 - Shire plc
5th Dec 201812:27 pmRNSForm 8.3 - Shire plc
5th Dec 201811:54 amRNSForm 8.5 - Shire Plc
5th Dec 201811:54 amRNSForm 8.3 - Shire plc
5th Dec 201811:40 amRNSForm 8.5 (EPT/NON-RI)
5th Dec 201811:36 amRNSForm 8.5 (EPT/RI)
5th Dec 201811:29 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
5th Dec 201811:20 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
5th Dec 201811:01 amRNSForm 8.3 - Shire Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.